299 related articles for article (PubMed ID: 19211093)
1. Effect of triamcinolone acetonide on vascular endothelial growth factor and occludin levels in branch retinal vein occlusion.
McAllister IL; Vijayasekaran S; Chen SD; Yu DY
Am J Ophthalmol; 2009 May; 147(5):838-46, 846.e1-2. PubMed ID: 19211093
[TBL] [Abstract][Full Text] [Related]
2. Retinal gene expression and Müller cell responses after branch retinal vein occlusion in the rat.
Rehak M; Hollborn M; Iandiev I; Pannicke T; Karl A; Wurm A; Kohen L; Reichenbach A; Wiedemann P; Bringmann A
Invest Ophthalmol Vis Sci; 2009 May; 50(5):2359-67. PubMed ID: 18806298
[TBL] [Abstract][Full Text] [Related]
3. Corticosteroids inhibit VEGF-induced vascular leakage in a rabbit model of blood-retinal and blood-aqueous barrier breakdown.
Edelman JL; Lutz D; Castro MR
Exp Eye Res; 2005 Feb; 80(2):249-58. PubMed ID: 15670803
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal triamcinolone acetonide induced changes in the anterior segment in a pig model of branch retinal vein occlusion.
Vijayasekaran S; McAllister IL; Morgan WH; Mendis KR; McMenamin PG; Cringle SJ; Yu DY
Graefes Arch Clin Exp Ophthalmol; 2011 Feb; 249(2):215-22. PubMed ID: 20652816
[TBL] [Abstract][Full Text] [Related]
5. Cytokine Levels in Experimental Branch Retinal Vein Occlusion Treated With Either Bevacizumab or Triamcinolone Acetonide.
McAllister IL; Vijayasekaran S; McLenachan S; Bhikoo R; Chen FK; Zhang D; Kanagalingam E; Yu DY
Transl Vis Sci Technol; 2024 Jun; 13(6):13. PubMed ID: 38899953
[TBL] [Abstract][Full Text] [Related]
6. Soluble vascular endothelial growth factor receptor-2 and inflammatory factors in macular edema with branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Eguchi S; Hori S
Am J Ophthalmol; 2011 Oct; 152(4):669-677.e1. PubMed ID: 21726846
[TBL] [Abstract][Full Text] [Related]
7. Aqueous vascular endothelial growth factor levels are associated with serous macular detachment secondary to branch retinal vein occlusion.
Park SP; Ahn JK; Mun GH
Retina; 2010 Feb; 30(2):281-6. PubMed ID: 19881397
[TBL] [Abstract][Full Text] [Related]
8. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6.
Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Jian K; Sakamoto I; Nakano K; Yamashita H; Minamoto A; Mishima HK
Am J Ophthalmol; 2005 Aug; 140(2):256-61. PubMed ID: 16086947
[TBL] [Abstract][Full Text] [Related]
9. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group.
Barber AJ; Antonetti DA; Gardner TW
Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253
[TBL] [Abstract][Full Text] [Related]
10. Vitreous levels of interleukin-6 and vascular endothelial growth factor in macular edema with central retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Harino S; Hori S
Ophthalmology; 2009 Jan; 116(1):87-93. PubMed ID: 19118700
[TBL] [Abstract][Full Text] [Related]
11. Association of inflammatory factors with macular edema in branch retinal vein occlusion.
Noma H; Mimura T; Eguchi S
JAMA Ophthalmol; 2013 Feb; 131(2):160-5. PubMed ID: 23411880
[TBL] [Abstract][Full Text] [Related]
12. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion.
Noma H; Funatsu H; Yamasaki M; Tsukamoto H; Mimura T; Sone T; Hirayama T; Tamura H; Yamashita H; Minamoto A; Mishima HK
Eye (Lond); 2008 Jan; 22(1):42-8. PubMed ID: 16826241
[TBL] [Abstract][Full Text] [Related]
13. Endostatin modulates VEGF-mediated barrier dysfunction in the retinal microvascular endothelium.
Brankin B; Campbell M; Canning P; Gardiner TA; Stitt AW
Exp Eye Res; 2005 Jul; 81(1):22-31. PubMed ID: 15978251
[TBL] [Abstract][Full Text] [Related]
14. [Inhtravitreal triamcinolone acetonide injections in the treatment of cystoid macular edema due to the central or branch retinal vein occlusion].
Lubczyńska A; Kociecki J
Klin Oczna; 2007; 109(4-6):169-72. PubMed ID: 17725278
[TBL] [Abstract][Full Text] [Related]
15. Monitoring ocular drug therapy by analysis of aqueous samples.
Campochiaro PA; Choy DF; Do DV; Hafiz G; Shah SM; Nguyen QD; Rubio R; Arron JR
Ophthalmology; 2009 Nov; 116(11):2158-64. PubMed ID: 19700195
[TBL] [Abstract][Full Text] [Related]
16. Effects of triamcinolone on the expression of VEGF and PEDF in human retinal pigment epithelial and human umbilical vein endothelial cells.
Tong JP; Lam DS; Chan WM; Choy KW; Chan KP; Pang CP
Mol Vis; 2006 Dec; 12():1490-5. PubMed ID: 17167405
[TBL] [Abstract][Full Text] [Related]
17. Involvement of MAPKs in endostatin-mediated regulation of blood-retinal barrier function.
Campbell M; Collery R; McEvoy A; Gardiner TA; Stitt AW; Brankin B
Curr Eye Res; 2006 Dec; 31(12):1033-45. PubMed ID: 17169842
[TBL] [Abstract][Full Text] [Related]
18. Influence of triamcinolone intravitreal injection on retinochoroidal healing processes.
Dot C; Behar-Cohen F; BenEzra D; Doat M; Jonet L; May F; Jeanny JC
Exp Eye Res; 2007 Jun; 84(6):1081-9. PubMed ID: 17408616
[TBL] [Abstract][Full Text] [Related]
19. Vitreous inflammatory factors and serous macular detachment in branch retinal vein occlusion.
Noma H; Funatsu H; Mimura T; Tatsugawa M; Shimada K; Eguchi S
Retina; 2012 Jan; 32(1):86-91. PubMed ID: 21866074
[TBL] [Abstract][Full Text] [Related]
20. Effects of periocular administration of triamcinolone acetonide on leukocyte-endothelium interactions in the ischemic retina.
Mizuno S; Nishiwaki A; Morita H; Miyake T; Ogura Y
Invest Ophthalmol Vis Sci; 2007 Jun; 48(6):2831-6. PubMed ID: 17525219
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
